Memory advancement by intranasal insulin in type 2 diabetes (MemAID) randomized controlled clinical trial: Design, methods and rationale
B. Galindo-Mendez(Harvard University), Vera Novak(Beth Israel Deaconess Medical Center), Jorge A. Trevino(Harvard University), Catherine B. Fortier(Harvard University), Regina E. McGlinchey(VA Boston Healthcare System), Long Ngo(Smile Train), Christos S. Mantzoros(Beth Israel Deaconess Medical Center), Vasileios Lioutas(Beth Israel Deaconess Medical Center), Péter Novák(Harvard University)
Cited by 28
Related Papers
Role of leptin in the neuroendocrine response to fasting
|Nature|1996|3.1k
Adverse metabolic and cardiovascular consequences of circadian misalignment
|Proceedings of the National Academy of Sciences|2009|2.3k
Obesity and cancer risk: Emerging biological mechanisms and perspectives
|Metabolism|2018|1.6k
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
|Metabolism|2018|1.2k